01801.HK
Innovent Biologics, Inc.
HKSE · Healthcare · Biotechnology · CN
HKD 96.60
+0.47%Next report
Analyst consensus
- Next report date
- Mar 31, 2027
- EPS estimate
- HKD 1.33
- Revenue estimate
- HKD 11.9B
Latest reported
- Last report date
- Aug 25, 2026
- EPS actual
- HKD 0.81
- EPS estimate
- HKD 0.54
- Revenue actual
- HKD 9.9B
- Revenue estimate
- HKD 10.3B
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 1
- EPS misses (12Q)
- 0
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +49.1%
- Revenue beats (12Q)
- 0
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 25, 2026 | HKD 0.54 | HKD 0.81 | Beat 49.08% | HKD 9.9B |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Mar 31, 2027